Petros Pharmaceuticals, Inc. Fair Value Adjustment of Warrants
Petros Pharmaceuticals, Inc. (PTPI) reported Fair Value Adjustment of Warrants of -$900 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- Petros Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$900.00, a 100.27% decline year-over-year.
- Petros Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$1.70K.
- Petros Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$1.00K.
- Petros Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $329.34K.
- Petros Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2025 was -$10.31M.
- Petros Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2023 was -$13.97M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$900.00 10-Q · filed 2026-08-13 | -$900.00 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | -$1.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$2.70K derived: sum of 2 quarters · filed 2026-04-15 | $326.64K derived: sum of 3 quarters · filed 2026-08-13 | -$10.31M 10-K · filed 2026-04-15 |
| 2025-09-30 | -$1.00K 10-Q · filed 2025-11-13 | $328.34K derived: sum of 2 quarters · filed 2026-08-13 | -$10.30M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $329.34K 10-Q · filed 2026-08-13 | -$10.30M 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$10.63M 10-Q · filed 2026-05-13 | |||
| 2023-12-31 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$13.97M derived: sum of 2 quarters · filed 2025-03-31 | -$13.97M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$11.74M 10-Q · filed 2024-11-13 | -$11.74M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |